Target intelligence / Profile preview

Gut mucosal surface and microbiota niche

Molecular classification
Biological niche, Ecosystem, Mucosal barrier, Other
01

Overview

The gut mucosal surface and microbiota niche represent a complex biological interface between the host's intestinal epithelium and the diverse microbial community residing within the gut lumen (Belkaid & Hand, 2014). This niche is characterized by a protective mucus layer, primarily composed of mucin glycoproteins, which serves as both a physical barrier and a nutrient source for commensal bacteria (Turner, 2009). Biologically, it plays a critical role in maintaining homeostasis by facilitating nutrient absorption, educating the mucosal immune system, and preventing the colonization of pathogens through competitive exclusion (Bäckhed et al., 2005). Dysregulation of this environment, often termed dysbiosis or barrier dysfunction, is linked to numerous pathologies, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), and metabolic disorders (Khoruts & Sadowsky, 2016). Therapeutic strategies targeting this niche aim to restore microbial balance and reinforce the mucosal barrier through the use of probiotics, prebiotics, and fecal microbiota transplants. Monitoring the health of this niche often involves assessing microbial diversity and measuring markers of intestinal permeability like zonulin or fecal calprotectin.

Other names
Intestinal mucosal barrierGut-microbiome interfaceMucosal-associated microbiotaIntestinal nicheGut mucosal interface
02

Mechanism of action

Modulation of microbial ecology, competitive inhibition of pathogens, and restoration of epithelial barrier integrity.

03

Biological functions

Immune system modulationPathogen exclusionNutrient metabolismMucus productionEpithelial barrier maintenance
04

Disease associations

Inflammatory bowel diseaseIrritable bowel syndromeObesityColorectal cancerMetabolic syndromeCeliac disease
05

Safety considerations

Risk of systemic infection (bacteremia)Transfer of antibiotic resistance genesDisruption of commensal flora (dysbiosis)Unpredictable host-microbe interactions
06

Interacting drugs

Rifaximin

4 more in the full profile.

07

Biomarkers

Fecal calprotectinZonulinMicrobial alpha-diversityShort-chain fatty acid levels

Beyond the preview

Go deeper on Gut mucosal surface and microbiota niche.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut mucosal surface and microbiota niche.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call